Quantamental Technologies’s Usana Health Sciences USNA Stock Holding History

Quantamental Technologies’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,000	Closed	-$205K	–	1302
2019 Q3	$205K	Buy	3,000 +210	+8%	+$14.1K	0.07%	495
2019 Q2	$222K	Sell	2,790 -588	-17%	-$46.6K	0.08%	396
2019 Q1	$283K	Buy	+3,378	New	+$353K	0.13%	255

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantamental Technologies's USNA Position: Q4 2019 in Review

Quantamental Technologies sold out of Usana Health Sciences (USNA) in Q4 2019, closing a stake of 3,000 shares — an estimated $205K sold.

Quantamental Technologies first reported a position in USNA in Q1 2019 and held it in 3 quarters. The position peaked at $283K in Q1 2019. 175 funds tracked by Wall St. Rank hold USNA as of Q4 2019.

Quantamental Technologies reported no remaining Usana Health Sciences position as of Q4 2019 after selling out during the quarter.
Quantamental Technologies sold 3,000 Usana Health Sciences shares in Q4 2019, an estimated $205K.
Quantamental Technologies first reported a position in Usana Health Sciences in Q1 2019 and held it in 3 quarters.
Quantamental Technologies's Usana Health Sciences position peaked at $283K in Q1 2019.
175 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.